News Headline Summary

Amgen (AMGN) pleads guilty to misbranding charge

- Charge was on the misbranding of Anemia drug.

Reaction details:

- Co. shares are unmoved in reaction to the news; trades USD 89.19 last.

Print 15:21, 18 Dec 2012 - US Equities - Source: Newswires